MedTrace Logo

Green Tea Extract for Endometriosis Treatment

NCT02832271 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 185

Last updated 2023-02-08

No results posted yet for this study

Summary

The purpose of the study is to evaluate the efficacy and safety of green tea in endometriosis.

Conditions

  • Endometriosis

Interventions

DRUG

SUNPHENON EGCg

SUNPHENON EGCg Oral, 400mg, twice per day

DRUG

Placebo

Placebo

Sponsors & Collaborators

  • Cancer Institute and Hospital, Chinese Academy of Medical Sciences

    collaborator OTHER

  • Sun Yat-sen University

    collaborator OTHER

  • Guangdong Provincial Hospital of Traditional Chinese Medicine

    collaborator OTHER

  • Jiangxi University of Traditional Chinese Medicine

    collaborator OTHER

  • Chinese University of Hong Kong

    lead OTHER

Principal Investigators

  • Ronald Wang, MD PhD · Chinese University of Hong Kong

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-08
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • Hong Kong

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02832271 on ClinicalTrials.gov